Back to results
US 2015/0105371 A1Published application
Co-crystals and salts of ccr3-inhibitors
AssigneeBoehringer Ingelheim International GmbH
InventorsMarkus FRANK, Hans HAEBERLE, Manuel HENRY, Thorsten PACHUR, Marco SANTAGOSTINO, Uwe STERTZ, Thomas TREBING, Ulrike WERTHMANN
Life of this patent
Estimating the term…
Abstract
This invention relates to co-crystals and salts of CCR3 inhibitors of formula 1, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases related with the CCR3-receptor.
Claims6
A crystalline salt of a compound of formula 1,
- wherein
- R1 is C1-6-alkyl, C1-6-haloalkyl, O—C1-6-haloalkyl, halogene;
- m is 1, 2 or 3;
- R2a and R2b are each independently selected from H, C1-6-alkyl, C1-6-alkenyl, C1-6-alkynyl, C3-6-cycloalkyl, COO—C1-6-alkyl, O—C1-6-alkyl, CONR2b.1R2b.2, halogene;
- R2b.1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl;
- R2b.2 is H, C1-6-alkyl;
- or R2b.1 and R2b.2 are together a C3-6-alkylene group forming with the nitrogen atom a heterocyclic ring, wherein optionally one carbon atom or the ring is replaced by an oxygen atom
- R3 is H, C1-6-alkyl, and
- X is an anion selected from the group consisting of chloride or dibenzoyltartrate, and
- j is 1 or 2.
7 more elements
Dependencies are inferred from the claim text.